+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 22Years - 75Years
All Genders
ID05003310

Study to Assess Safety and Effects of Splenic Nerve Stimulation Using the Galvani System in Adults with Active Rheumatoid Arthritis Who Have Not Responded to Biologic or JAK Inhibitor Treatments

Led by Galvani Bioelectronics · Updated on 2024-05-22

28

Participants Needed

14

Research Sites

248 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to evaluate the safety, tolerability, and effects of stimulating the splenic neurovascular bundle using the Galvani System in people with active rheumatoid arthritis RA. Participants must have active RA with an inadequate response or intolerance to at least two biologic Disease Modifying Anti-Rheumatic Drugs DMARDs or JAK inhibitors. The study includes four distinct periods a randomized control trial, an open label phase, a treat-to-target phase, and a long-term follow-up, to thoroughly assess the treatment over time. Participants who receive the implantable system will be randomly assigned to either active stimulation or sham stimulation for 12 weeks in the first period. In the second period, responders to stimulation continue it, while non-responders or those who had sham stimulation receive an approved RA drug, baricitinib, for 12 weeks. In the third period, participants showing improvement but still with RA symptoms receive combined therapy of stimulation and baricitinib for up to 24 weeks. The fourth period provides a long-term safety follow-up lasting up to 5 years, during which participants may receive stimulation with other standard treatments as judged appropriate. Throughout the study, participants will undergo assessments including monitoring for adverse events, changes in RA disease activity scores, inflammatory markers, and questionnaires on physical and mental health. The study will track safety and tolerability during each period, with long-term follow-up to observe ongoing effects. The total participation duration extends over several years, with detailed monitoring to evaluate the implantable devices performance and impact on RA symptoms.

CONDITIONS

Brief Title

ConsideRAte Study - Splenic Stimulation for RA

Research Team

O

Operations Director

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here